

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.95659570 |
| 2 | muscle filament sliding (GO:0030049) | 6.95659570 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.68117827 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 6.54782670 |
| 5 | skeletal muscle contraction (GO:0003009) | 6.39779414 |
| 6 | actin-mediated cell contraction (GO:0070252) | 5.88140280 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.17598569 |
| 8 | skeletal muscle adaptation (GO:0043501) | 5.00397375 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.91591447 |
| 10 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.85293832 |
| 11 | regulation of cell communication by electrical coupling (GO:0010649) | 4.81174399 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.72793341 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.71649514 |
| 14 | plasma membrane repair (GO:0001778) | 4.61240410 |
| 15 | striated muscle contraction (GO:0006941) | 4.42443396 |
| 16 | actin filament-based movement (GO:0030048) | 4.41000786 |
| 17 | skeletal muscle fiber development (GO:0048741) | 4.31857244 |
| 18 | sarcomere organization (GO:0045214) | 4.28517280 |
| 19 | myofibril assembly (GO:0030239) | 4.20022633 |
| 20 | response to inactivity (GO:0014854) | 4.05190155 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.01310356 |
| 22 | neuromuscular synaptic transmission (GO:0007274) | 3.95124391 |
| 23 | myotube cell development (GO:0014904) | 3.91062815 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.83781919 |
| 25 | positive regulation of myotube differentiation (GO:0010831) | 3.82980655 |
| 26 | skeletal muscle tissue development (GO:0007519) | 3.70941236 |
| 27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.68024350 |
| 28 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.67478235 |
| 29 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.66140469 |
| 30 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.66140469 |
| 31 | vocalization behavior (GO:0071625) | 3.61617860 |
| 32 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.52929788 |
| 33 | regulation of membrane repolarization (GO:0060306) | 3.50999922 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.45125347 |
| 35 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44095966 |
| 36 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44095966 |
| 37 | muscle contraction (GO:0006936) | 3.41594233 |
| 38 | membrane depolarization during action potential (GO:0086010) | 3.40393427 |
| 39 | regulation of relaxation of muscle (GO:1901077) | 3.40133441 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.39590852 |
| 41 | neuron cell-cell adhesion (GO:0007158) | 3.39410410 |
| 42 | negative regulation of muscle hypertrophy (GO:0014741) | 3.35320132 |
| 43 | muscle cell fate commitment (GO:0042693) | 3.29552278 |
| 44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.28552810 |
| 45 | muscle cell cellular homeostasis (GO:0046716) | 3.25956594 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.24699962 |
| 47 | cardiac muscle contraction (GO:0060048) | 3.20555744 |
| 48 | striated muscle atrophy (GO:0014891) | 3.20293698 |
| 49 | polysaccharide catabolic process (GO:0000272) | 3.18463826 |
| 50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.18323912 |
| 51 | glycogen biosynthetic process (GO:0005978) | 3.18063731 |
| 52 | glucan biosynthetic process (GO:0009250) | 3.18063731 |
| 53 | actomyosin structure organization (GO:0031032) | 3.17697923 |
| 54 | striated muscle adaptation (GO:0014888) | 3.15431909 |
| 55 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.14173656 |
| 56 | muscle atrophy (GO:0014889) | 3.13362717 |
| 57 | muscle fiber development (GO:0048747) | 3.13344052 |
| 58 | protein localization to synapse (GO:0035418) | 3.12867390 |
| 59 | glycogen catabolic process (GO:0005980) | 3.12658167 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12101014 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.11327458 |
| 62 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.11101378 |
| 63 | muscle system process (GO:0003012) | 3.10876095 |
| 64 | detection of calcium ion (GO:0005513) | 3.08758919 |
| 65 | locomotory exploration behavior (GO:0035641) | 3.08480167 |
| 66 | response to activity (GO:0014823) | 3.07423836 |
| 67 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.07200292 |
| 68 | synaptic vesicle maturation (GO:0016188) | 3.04964275 |
| 69 | cardiac muscle hypertrophy (GO:0003300) | 3.04107515 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03253090 |
| 71 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.02826561 |
| 72 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.01421446 |
| 73 | postsynaptic membrane organization (GO:0001941) | 2.99838155 |
| 74 | cardiac myofibril assembly (GO:0055003) | 2.99734974 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 2.98779182 |
| 76 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.98250155 |
| 77 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.96298271 |
| 78 | regulation of actin filament-based movement (GO:1903115) | 2.94698854 |
| 79 | NADH metabolic process (GO:0006734) | 2.93107189 |
| 80 | response to parathyroid hormone (GO:0071107) | 2.90434825 |
| 81 | presynaptic membrane organization (GO:0097090) | 2.90235533 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.90203542 |
| 83 | neuron recognition (GO:0008038) | 2.89571757 |
| 84 | fructose metabolic process (GO:0006000) | 2.89396606 |
| 85 | negative regulation of muscle contraction (GO:0045932) | 2.89261876 |
| 86 | regulation of synapse maturation (GO:0090128) | 2.89235243 |
| 87 | glucan catabolic process (GO:0009251) | 2.87394724 |
| 88 | gluconeogenesis (GO:0006094) | 2.87094497 |
| 89 | striated muscle hypertrophy (GO:0014897) | 2.86758062 |
| 90 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.85361563 |
| 91 | glycogen metabolic process (GO:0005977) | 2.85136688 |
| 92 | calcium ion import (GO:0070509) | 2.84607176 |
| 93 | cerebellar granule cell differentiation (GO:0021707) | 2.84399049 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.83752438 |
| 95 | striated muscle cell development (GO:0055002) | 2.81890669 |
| 96 | presynaptic membrane assembly (GO:0097105) | 2.81393349 |
| 97 | regulation of cation channel activity (GO:2001257) | 2.80207206 |
| 98 | regulation of synaptic vesicle transport (GO:1902803) | 2.79513046 |
| 99 | 2-oxoglutarate metabolic process (GO:0006103) | 2.79159131 |
| 100 | glucan metabolic process (GO:0044042) | 2.78193800 |
| 101 | cellular glucan metabolic process (GO:0006073) | 2.78193800 |
| 102 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.77978772 |
| 103 | skeletal muscle tissue regeneration (GO:0043403) | 2.77796612 |
| 104 | positive regulation of cation channel activity (GO:2001259) | 2.76989119 |
| 105 | carnitine shuttle (GO:0006853) | 2.76833289 |
| 106 | dendritic spine morphogenesis (GO:0060997) | 2.76653785 |
| 107 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.76581703 |
| 108 | synaptic vesicle exocytosis (GO:0016079) | 2.74990415 |
| 109 | response to muscle activity (GO:0014850) | 2.73685302 |
| 110 | neuronal action potential (GO:0019228) | 2.73505982 |
| 111 | synaptic transmission, cholinergic (GO:0007271) | 2.72471647 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.71995608 |
| 113 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.71728721 |
| 114 | positive regulation of myoblast differentiation (GO:0045663) | 2.70215854 |
| 115 | axonal fasciculation (GO:0007413) | 2.69546209 |
| 116 | creatine metabolic process (GO:0006600) | 2.68344803 |
| 117 | respiratory system process (GO:0003016) | 2.68192818 |
| 118 | muscle organ development (GO:0007517) | 2.67943503 |
| 119 | heart process (GO:0003015) | 2.66973575 |
| 120 | neuron-neuron synaptic transmission (GO:0007270) | 2.66033116 |
| 121 | muscle structure development (GO:0061061) | 2.65282404 |
| 122 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.64291112 |
| 123 | muscle adaptation (GO:0043500) | 2.61911972 |
| 124 | glutamate receptor signaling pathway (GO:0007215) | 2.60464204 |
| 125 | cellular polysaccharide catabolic process (GO:0044247) | 2.60400727 |
| 126 | glutamate secretion (GO:0014047) | 2.59139262 |
| 127 | myoblast fusion (GO:0007520) | 2.56563870 |
| 128 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.55069186 |
| 129 | myotube differentiation (GO:0014902) | 2.55062776 |
| 130 | membrane depolarization (GO:0051899) | 2.54416432 |
| 131 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.53144800 |
| 132 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.52401155 |
| 133 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.52302633 |
| 134 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.51960458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01680037 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24720482 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.05840849 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.83480170 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.79208799 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67498477 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61068218 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.53521625 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.53521625 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.51389201 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45302913 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41110763 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34816429 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25255790 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23540342 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22293460 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21370013 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.20364081 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19672665 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18904561 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16611873 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13943094 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08392271 |
| 24 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02634906 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00565363 |
| 26 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.90856838 |
| 27 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.89828260 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88703221 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87546550 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.86828808 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.82841941 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78983935 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78816750 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78031732 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76495617 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.76090840 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73067005 |
| 38 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71002737 |
| 39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.69619287 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63339569 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63331432 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60724470 |
| 43 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57902627 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57728280 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56484110 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.54385192 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53485896 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53295097 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51540325 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51435122 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45935210 |
| 52 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43839599 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43553181 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43471485 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41847296 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41284873 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.39351104 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38761896 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37527500 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36685890 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.34827901 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34418808 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33104074 |
| 64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31966651 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31100426 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29947979 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27055087 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26958611 |
| 69 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.25377453 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25166272 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24715866 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24715866 |
| 73 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24192865 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23325842 |
| 75 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.21758761 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21720368 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21593250 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21189430 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20962255 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20411936 |
| 81 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20322886 |
| 82 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.20273645 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19508797 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19170559 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18379261 |
| 86 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17973498 |
| 87 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17488397 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17282443 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16615602 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16424498 |
| 91 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16257575 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15935465 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15597667 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14412002 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14384429 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14153482 |
| 97 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.13616654 |
| 98 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13230568 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12276628 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09972471 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09893947 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09743236 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09465410 |
| 104 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08747915 |
| 105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07590658 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07576260 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07379541 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06754441 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06728720 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06508027 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06165580 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05938946 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05266123 |
| 114 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04494863 |
| 115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04163149 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03731071 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02938300 |
| 118 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02922126 |
| 119 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01962896 |
| 120 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01693510 |
| 121 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01332990 |
| 122 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.01010673 |
| 123 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00497153 |
| 124 | * AR_19668381_ChIP-Seq_PC3_Human | 1.00361249 |
| 125 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.99898182 |
| 126 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99609888 |
| 127 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.98934168 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98904680 |
| 129 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98893468 |
| 130 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98785450 |
| 131 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98323708 |
| 132 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97927635 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97078934 |
| 134 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96995549 |
| 135 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96875378 |
| 136 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96632561 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95054159 |
| 138 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94891752 |
| 139 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94827501 |
| 140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94656199 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94559652 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94506438 |
| 143 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94332833 |
| 144 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93994483 |
| 145 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93807748 |
| 146 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93495622 |
| 147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93195463 |
| 148 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93021231 |
| 149 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93021231 |
| 150 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92934251 |
| 151 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92650613 |
| 152 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91993511 |
| 153 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91839469 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91365200 |
| 155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90469733 |
| 156 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89942481 |
| 157 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.89778280 |
| 158 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88660326 |
| 159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88244963 |
| 160 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87913592 |
| 161 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87803685 |
| 162 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87360423 |
| 163 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86795372 |
| 164 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85143163 |
| 165 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84656841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.48692817 |
| 2 | MP0000751_myopathy | 4.64433754 |
| 3 | MP0003646_muscle_fatigue | 4.61388804 |
| 4 | MP0000749_muscle_degeneration | 4.33566898 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.50962755 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.20436928 |
| 7 | MP0004270_analgesia | 3.07820392 |
| 8 | MP0005451_abnormal_body_composition | 3.05809437 |
| 9 | MP0002106_abnormal_muscle_physiology | 2.90394193 |
| 10 | MP0000747_muscle_weakness | 2.81191570 |
| 11 | MP0004036_abnormal_muscle_relaxation | 2.63246239 |
| 12 | MP0000759_abnormal_skeletal_muscle | 2.61247295 |
| 13 | MP0005369_muscle_phenotype | 2.47516445 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.36468358 |
| 15 | MP0003880_abnormal_central_pattern | 2.36105908 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.29802733 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.22818953 |
| 18 | MP0002269_muscular_atrophy | 2.08036083 |
| 19 | MP0000750_abnormal_muscle_regeneration | 1.96983127 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 1.95386690 |
| 21 | MP0004510_myositis | 1.93919981 |
| 22 | MP0005423_abnormal_somatic_nervous | 1.93724582 |
| 23 | MP0009745_abnormal_behavioral_response | 1.88913608 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.79562585 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.70567134 |
| 26 | MP0004233_abnormal_muscle_weight | 1.68184650 |
| 27 | MP0001486_abnormal_startle_reflex | 1.66289857 |
| 28 | MP0009046_muscle_twitch | 1.58796616 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.57572264 |
| 30 | MP0002822_catalepsy | 1.57183704 |
| 31 | MP0002064_seizures | 1.55912975 |
| 32 | * MP0004130_abnormal_muscle_cell | 1.53922078 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.51295935 |
| 34 | MP0002272_abnormal_nervous_system | 1.47013423 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.46930515 |
| 36 | MP0003137_abnormal_impulse_conducting | 1.46829176 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.46155916 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.45282770 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.42085677 |
| 40 | MP0002184_abnormal_innervation | 1.40321410 |
| 41 | MP0004484_altered_response_of | 1.40262244 |
| 42 | MP0005330_cardiomyopathy | 1.38401830 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.38382225 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.33124565 |
| 45 | MP0000778_abnormal_nervous_system | 1.31629790 |
| 46 | MP0008569_lethality_at_weaning | 1.30961620 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.29273930 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.29075242 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.28499915 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.27048992 |
| 51 | MP0001188_hyperpigmentation | 1.25826900 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.24255914 |
| 53 | MP0005646_abnormal_pituitary_gland | 1.21909108 |
| 54 | MP0001984_abnormal_olfaction | 1.15637224 |
| 55 | MP0002557_abnormal_social/conspecific_i | 1.14739088 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.14100004 |
| 57 | MP0001970_abnormal_pain_threshold | 1.14032243 |
| 58 | MP0000733_abnormal_muscle_development | 1.13407322 |
| 59 | MP0002736_abnormal_nociception_after | 1.12151404 |
| 60 | MP0000955_abnormal_spinal_cord | 1.09150136 |
| 61 | MP0004142_abnormal_muscle_tone | 1.06515486 |
| 62 | MP0004858_abnormal_nervous_system | 1.04376607 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.03956093 |
| 64 | MP0006138_congestive_heart_failure | 1.01980700 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.01331029 |
| 66 | MP0003123_paternal_imprinting | 1.01199202 |
| 67 | MP0004085_abnormal_heartbeat | 1.00899266 |
| 68 | MP0002234_abnormal_pharynx_morphology | 0.99263005 |
| 69 | MP0002882_abnormal_neuron_morphology | 0.98476986 |
| 70 | MP0003329_amyloid_beta_deposits | 0.98335746 |
| 71 | MP0004811_abnormal_neuron_physiology | 0.98255537 |
| 72 | MP0005386_behavior/neurological_phenoty | 0.95318195 |
| 73 | MP0004924_abnormal_behavior | 0.95318195 |
| 74 | MP0004185_abnormal_adipocyte_glucose | 0.92351728 |
| 75 | MP0001502_abnormal_circadian_rhythm | 0.91026800 |
| 76 | MP0001529_abnormal_vocalization | 0.90122615 |
| 77 | MP0005266_abnormal_metabolism | 0.88779707 |
| 78 | MP0002971_abnormal_brown_adipose | 0.88024258 |
| 79 | MP0001501_abnormal_sleep_pattern | 0.86149848 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.85899984 |
| 81 | MP0005464_abnormal_platelet_physiology | 0.81761880 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.80853778 |
| 83 | MP0003879_abnormal_hair_cell | 0.80238169 |
| 84 | MP0004742_abnormal_vestibular_system | 0.79682032 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.79545302 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.79183546 |
| 87 | MP0002102_abnormal_ear_morphology | 0.75618872 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.75358176 |
| 89 | MP0008874_decreased_physiological_sensi | 0.74473477 |
| 90 | MP0002909_abnormal_adrenal_gland | 0.74319493 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.73891480 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.73632128 |
| 93 | MP0005171_absent_coat_pigmentation | 0.73552183 |
| 94 | MP0009250_abnormal_appendicular_skeleto | 0.73188642 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.72573469 |
| 96 | MP0005535_abnormal_body_temperature | 0.69921421 |
| 97 | MP0005409_darkened_coat_color | 0.68105839 |
| 98 | MP0002127_abnormal_cardiovascular_syste | 0.67480657 |
| 99 | MP0001905_abnormal_dopamine_level | 0.67165919 |
| 100 | MP0004043_abnormal_pH_regulation | 0.66862142 |
| 101 | MP0001544_abnormal_cardiovascular_syste | 0.64948479 |
| 102 | MP0005385_cardiovascular_system_phenoty | 0.64948479 |
| 103 | MP0008775_abnormal_heart_ventricle | 0.64304137 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.63579921 |
| 105 | MP0003045_fibrosis | 0.63108924 |
| 106 | MP0003075_altered_response_to | 0.62949855 |
| 107 | MP0002152_abnormal_brain_morphology | 0.62373713 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.62047100 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.61820513 |
| 110 | MP0004885_abnormal_endolymph | 0.61190698 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 0.61181472 |
| 112 | MP0004134_abnormal_chest_morphology | 0.61101512 |
| 113 | MP0003828_pulmonary_edema | 0.60904154 |
| 114 | MP0003787_abnormal_imprinting | 0.60824952 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.59512649 |
| 116 | MP0003705_abnormal_hypodermis_morpholog | 0.58203035 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.57872277 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57740228 |
| 119 | MP0009840_abnormal_foam_cell | 0.55549441 |
| 120 | MP0003633_abnormal_nervous_system | 0.55465825 |
| 121 | MP0000026_abnormal_inner_ear | 0.55323398 |
| 122 | MP0000343_altered_response_to | 0.55062808 |
| 123 | MP0002229_neurodegeneration | 0.54748327 |
| 124 | MP0005083_abnormal_biliary_tract | 0.53539939 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.51945934 |
| 126 | MP0005166_decreased_susceptibility_to | 0.49617250 |
| 127 | MP0004147_increased_porphyrin_level | 0.47706742 |
| 128 | MP0000920_abnormal_myelination | 0.47706241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.05333472 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.79258992 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.51475064 |
| 4 | Nemaline bodies (HP:0003798) | 7.37611683 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.55074279 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.23812131 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 6.03598784 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 5.77230153 |
| 9 | Distal arthrogryposis (HP:0005684) | 5.53629506 |
| 10 | Myopathic facies (HP:0002058) | 5.27748980 |
| 11 | Difficulty running (HP:0009046) | 4.53690928 |
| 12 | Muscle fiber splitting (HP:0003555) | 4.53372810 |
| 13 | Round ear (HP:0100830) | 4.50782503 |
| 14 | EMG: myopathic abnormalities (HP:0003458) | 4.28766259 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.28437702 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 4.05908873 |
| 17 | Myotonia (HP:0002486) | 4.04999093 |
| 18 | Ulnar deviation of the wrist (HP:0003049) | 4.01848250 |
| 19 | Calcaneovalgus deformity (HP:0001848) | 3.77581836 |
| 20 | Muscle stiffness (HP:0003552) | 3.70938837 |
| 21 | Myoglobinuria (HP:0002913) | 3.70886636 |
| 22 | Absent phalangeal crease (HP:0006109) | 3.62857617 |
| 23 | Focal motor seizures (HP:0011153) | 3.55095387 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.50269781 |
| 25 | Subaortic stenosis (HP:0001682) | 3.50269781 |
| 26 | Deformed tarsal bones (HP:0008119) | 3.47576296 |
| 27 | Sudden death (HP:0001699) | 3.41513581 |
| 28 | Fetal akinesia sequence (HP:0001989) | 3.30426378 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.23802630 |
| 30 | Abnormal finger flexion creases (HP:0006143) | 3.17330676 |
| 31 | Increased connective tissue (HP:0009025) | 3.13467366 |
| 32 | Neck muscle weakness (HP:0000467) | 3.03105938 |
| 33 | Rimmed vacuoles (HP:0003805) | 3.03044722 |
| 34 | Hyperkalemia (HP:0002153) | 3.01608577 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.99240996 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 2.95907212 |
| 37 | Malignant hyperthermia (HP:0002047) | 2.91401825 |
| 38 | Difficulty climbing stairs (HP:0003551) | 2.85681709 |
| 39 | Rhabdomyolysis (HP:0003201) | 2.71710337 |
| 40 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.62674989 |
| 41 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.62674989 |
| 42 | Fatigable weakness (HP:0003473) | 2.61180504 |
| 43 | Abnormality of the neuromuscular junction (HP:0003398) | 2.61180504 |
| 44 | Pelvic girdle muscle weakness (HP:0003749) | 2.60942099 |
| 45 | Febrile seizures (HP:0002373) | 2.59797912 |
| 46 | Areflexia of lower limbs (HP:0002522) | 2.53263899 |
| 47 | Frequent falls (HP:0002359) | 2.50967167 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.45258594 |
| 49 | Broad-based gait (HP:0002136) | 2.38733159 |
| 50 | Lower limb amyotrophy (HP:0007210) | 2.33680599 |
| 51 | Bulbar palsy (HP:0001283) | 2.31830715 |
| 52 | Bundle branch block (HP:0011710) | 2.27416457 |
| 53 | Nonprogressive disorder (HP:0003680) | 2.26975922 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.26344613 |
| 55 | Myokymia (HP:0002411) | 2.24933140 |
| 56 | Abnormal atrioventricular conduction (HP:0005150) | 2.20685077 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.19260841 |
| 58 | Prolonged QT interval (HP:0001657) | 2.18076873 |
| 59 | Focal seizures (HP:0007359) | 2.16419164 |
| 60 | Muscular dystrophy (HP:0003560) | 2.13945947 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.12632808 |
| 62 | Muscle fiber atrophy (HP:0100295) | 2.12584063 |
| 63 | Visual hallucinations (HP:0002367) | 2.11309667 |
| 64 | Gowers sign (HP:0003391) | 2.08767781 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.05621076 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00296423 |
| 67 | Limb-girdle muscle weakness (HP:0003325) | 2.00142426 |
| 68 | Hip contracture (HP:0003273) | 1.99653482 |
| 69 | Ventricular tachycardia (HP:0004756) | 1.99530730 |
| 70 | Atrial fibrillation (HP:0005110) | 1.99303498 |
| 71 | Generalized tonic-clonic seizures (HP:0002069) | 1.98687487 |
| 72 | Proximal amyotrophy (HP:0007126) | 1.97548204 |
| 73 | Atonic seizures (HP:0010819) | 1.92270020 |
| 74 | Generalized muscle weakness (HP:0003324) | 1.91772206 |
| 75 | Primary atrial arrhythmia (HP:0001692) | 1.91126906 |
| 76 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90897417 |
| 77 | Abnormal EKG (HP:0003115) | 1.90366302 |
| 78 | Weak cry (HP:0001612) | 1.89983322 |
| 79 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.87729308 |
| 80 | Slender build (HP:0001533) | 1.87367298 |
| 81 | Popliteal pterygium (HP:0009756) | 1.86229671 |
| 82 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.83644650 |
| 83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81894996 |
| 84 | Lipoatrophy (HP:0100578) | 1.80192578 |
| 85 | Progressive muscle weakness (HP:0003323) | 1.80136928 |
| 86 | Supraventricular tachycardia (HP:0004755) | 1.78576207 |
| 87 | Abnormality of the calcaneus (HP:0008364) | 1.75467048 |
| 88 | Metatarsus adductus (HP:0001840) | 1.74961966 |
| 89 | Easy fatigability (HP:0003388) | 1.74450991 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.74116479 |
| 91 | Left ventricular hypertrophy (HP:0001712) | 1.72382564 |
| 92 | Supraventricular arrhythmia (HP:0005115) | 1.70774930 |
| 93 | Akinesia (HP:0002304) | 1.70318692 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 1.69996325 |
| 95 | Absence seizures (HP:0002121) | 1.68763594 |
| 96 | Ventricular arrhythmia (HP:0004308) | 1.67705469 |
| 97 | Epileptic encephalopathy (HP:0200134) | 1.66600495 |
| 98 | Heart block (HP:0012722) | 1.66478701 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.65809120 |
| 100 | Spinal rigidity (HP:0003306) | 1.65428260 |
| 101 | Scapular winging (HP:0003691) | 1.64994040 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 1.63315037 |
| 103 | Type 2 muscle fiber atrophy (HP:0003554) | 1.62802250 |
| 104 | Ventricular fibrillation (HP:0001663) | 1.62634452 |
| 105 | Abnormality of potassium homeostasis (HP:0011042) | 1.62093316 |
| 106 | Hypoplastic ischia (HP:0003175) | 1.62091804 |
| 107 | Waddling gait (HP:0002515) | 1.61862567 |
| 108 | Ulnar deviation of finger (HP:0009465) | 1.61379819 |
| 109 | Abnormality of the foot musculature (HP:0001436) | 1.59041160 |
| 110 | Paralysis (HP:0003470) | 1.57675034 |
| 111 | Syncope (HP:0001279) | 1.56437568 |
| 112 | Adducted thumb (HP:0001181) | 1.55408097 |
| 113 | Ragged-red muscle fibers (HP:0003200) | 1.55243839 |
| 114 | Poor eye contact (HP:0000817) | 1.54328129 |
| 115 | Dialeptic seizures (HP:0011146) | 1.53726978 |
| 116 | Atrioventricular block (HP:0001678) | 1.41291033 |
| 117 | Rapidly progressive (HP:0003678) | 1.40459478 |
| 118 | Congenital hip dislocation (HP:0001374) | 1.37972654 |
| 119 | Stridor (HP:0010307) | 1.37785739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.58589437 |
| 2 | PHKG2 | 4.92365541 |
| 3 | PHKG1 | 4.92365541 |
| 4 | MARK1 | 3.43560406 |
| 5 | TTN | 3.38401204 |
| 6 | NME1 | 2.64184322 |
| 7 | NTRK3 | 2.60144256 |
| 8 | INSRR | 2.54663022 |
| 9 | PINK1 | 2.43794559 |
| 10 | MUSK | 1.95864227 |
| 11 | EPHA4 | 1.89736857 |
| 12 | TNIK | 1.81960881 |
| 13 | PIK3CG | 1.77643056 |
| 14 | CASK | 1.71383756 |
| 15 | MAPK13 | 1.70580715 |
| 16 | MAP2K4 | 1.68179796 |
| 17 | MAP2K7 | 1.64814842 |
| 18 | MAP3K9 | 1.64658610 |
| 19 | MAP3K4 | 1.53421344 |
| 20 | MAP3K7 | 1.49526590 |
| 21 | PIK3CA | 1.40366298 |
| 22 | DMPK | 1.37300774 |
| 23 | MAP3K11 | 1.36802769 |
| 24 | PKN1 | 1.32452736 |
| 25 | MINK1 | 1.31678257 |
| 26 | MAPKAPK3 | 1.30068402 |
| 27 | PAK6 | 1.29555437 |
| 28 | ZAK | 1.29041428 |
| 29 | ARAF | 1.26886892 |
| 30 | NTRK2 | 1.25893607 |
| 31 | MAPK12 | 1.18406282 |
| 32 | MOS | 1.15918020 |
| 33 | ERBB3 | 1.14750245 |
| 34 | DYRK1B | 1.14536346 |
| 35 | RIPK1 | 1.08060634 |
| 36 | PRPF4B | 1.05765723 |
| 37 | NEK1 | 1.04829305 |
| 38 | DAPK2 | 1.02944474 |
| 39 | MAP2K6 | 1.01820633 |
| 40 | EEF2K | 1.01600830 |
| 41 | TRIB3 | 1.00188708 |
| 42 | LIMK1 | 0.97316191 |
| 43 | ICK | 0.89748597 |
| 44 | MAP3K12 | 0.84250063 |
| 45 | KSR1 | 0.81366921 |
| 46 | PRKD3 | 0.80208585 |
| 47 | STK24 | 0.78219848 |
| 48 | PDK3 | 0.78019136 |
| 49 | PDK4 | 0.78019136 |
| 50 | SIK1 | 0.77370831 |
| 51 | BCKDK | 0.76386944 |
| 52 | CDK5 | 0.75908836 |
| 53 | PRKAA1 | 0.75112083 |
| 54 | PNCK | 0.74418251 |
| 55 | UHMK1 | 0.74359182 |
| 56 | TAOK2 | 0.72877301 |
| 57 | IRAK2 | 0.72863578 |
| 58 | RIPK4 | 0.70837645 |
| 59 | SGK1 | 0.70321116 |
| 60 | SGK2 | 0.70197566 |
| 61 | DAPK3 | 0.69402190 |
| 62 | CAMK2A | 0.68383696 |
| 63 | PDPK1 | 0.67572195 |
| 64 | CCNB1 | 0.67256361 |
| 65 | CAMK2G | 0.66283259 |
| 66 | MARK2 | 0.66202121 |
| 67 | MAP2K3 | 0.66034723 |
| 68 | PRKCG | 0.64576806 |
| 69 | CDK19 | 0.63875857 |
| 70 | GRK5 | 0.63815705 |
| 71 | SIK2 | 0.63074009 |
| 72 | NEK6 | 0.62852139 |
| 73 | CAMK1 | 0.62719645 |
| 74 | TYRO3 | 0.62174570 |
| 75 | SGK494 | 0.62122904 |
| 76 | SGK223 | 0.62122904 |
| 77 | PLK2 | 0.61263493 |
| 78 | DYRK2 | 0.58732364 |
| 79 | STK11 | 0.58070628 |
| 80 | LMTK2 | 0.57551466 |
| 81 | PRKAA2 | 0.55768422 |
| 82 | GRK7 | 0.55412133 |
| 83 | BMX | 0.54612825 |
| 84 | STK38 | 0.53357153 |
| 85 | BRAF | 0.52831786 |
| 86 | RPS6KA2 | 0.52789979 |
| 87 | MAP2K1 | 0.52487242 |
| 88 | CAMK2D | 0.52085286 |
| 89 | CDC42BPA | 0.51569195 |
| 90 | MAPK4 | 0.51531163 |
| 91 | IRAK3 | 0.51179808 |
| 92 | SGK3 | 0.50915348 |
| 93 | SIK3 | 0.50730999 |
| 94 | PDK2 | 0.50536617 |
| 95 | PAK3 | 0.49883567 |
| 96 | LATS2 | 0.49489435 |
| 97 | PDK1 | 0.49064689 |
| 98 | PRKCE | 0.48182173 |
| 99 | ROCK1 | 0.47622154 |
| 100 | BMPR2 | 0.46357169 |
| 101 | PRKD2 | 0.46281577 |
| 102 | KSR2 | 0.46105892 |
| 103 | TNK2 | 0.45488455 |
| 104 | PRKG1 | 0.44358859 |
| 105 | TESK1 | 0.43975707 |
| 106 | MAPK7 | 0.43836070 |
| 107 | PRKACA | 0.40964026 |
| 108 | TAOK1 | 0.40449861 |
| 109 | MAP3K6 | 0.39592427 |
| 110 | RPS6KA3 | 0.39496402 |
| 111 | CDK15 | 0.39446219 |
| 112 | TRPM7 | 0.39221556 |
| 113 | PRKG2 | 0.39075206 |
| 114 | GRK1 | 0.38786107 |
| 115 | TBK1 | 0.38308336 |
| 116 | CAMKK1 | 0.38120607 |
| 117 | CDK11A | 0.37834227 |
| 118 | DDR2 | 0.37605156 |
| 119 | CAMK4 | 0.37414435 |
| 120 | MAP3K13 | 0.37024959 |
| 121 | DAPK1 | 0.36779903 |
| 122 | EPHB2 | 0.36630084 |
| 123 | DYRK1A | 0.35813558 |
| 124 | CAMK2B | 0.35221807 |
| 125 | CDK14 | 0.33908139 |
| 126 | PRKACB | 0.33681930 |
| 127 | MAPK10 | 0.33600000 |
| 128 | AKT2 | 0.32439797 |
| 129 | MAP3K1 | 0.32356523 |
| 130 | WNK1 | 0.32152176 |
| 131 | PRKCH | 0.31552240 |
| 132 | PRKD1 | 0.30006725 |
| 133 | IRAK1 | 0.29957683 |
| 134 | CDK3 | 0.28862450 |
| 135 | ROCK2 | 0.28777120 |
| 136 | CDK18 | 0.26699700 |
| 137 | NTRK1 | 0.26609392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.12308380 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.80073995 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.69253187 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67220214 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56556151 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.52156654 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.38035094 |
| 8 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.26532307 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.20319254 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.16357347 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10939551 |
| 12 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.10023882 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95851025 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.95379514 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.94515999 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.89343211 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.86058843 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.72063591 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69356855 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62568001 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.59929315 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.57915427 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56722740 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.52342252 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.52255933 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51793865 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46593807 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.46469900 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.43654864 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.43535606 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42521896 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40996272 |
| 33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.39906272 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.37193324 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.32930948 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.31050285 |
| 37 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.28621404 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26957087 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26013318 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.22240296 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19487873 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.18491529 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16683613 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11919710 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08738354 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05107553 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04090189 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02732563 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.02724184 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02681235 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01502481 |
| 52 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.01061582 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00557185 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.96580819 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95675992 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95356306 |
| 57 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94363207 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91093975 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.89717081 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.88267343 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85603939 |
| 62 | Tight junction_Homo sapiens_hsa04530 | 0.82999783 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81143812 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73821972 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73197477 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72986413 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72088936 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70754667 |
| 69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70494634 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69363106 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.66599908 |
| 72 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66483070 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65333635 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65224219 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64391240 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.63974645 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61850635 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61085275 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58330178 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57511433 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56856397 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55455141 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54955727 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54780013 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54329273 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.53860862 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.52136079 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51953149 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51519380 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51384901 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51084785 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51036866 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49794950 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49480958 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48427182 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46376187 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45817770 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45633288 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44923725 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.44803906 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44104424 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43673285 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43409403 |
| 104 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43047183 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42516970 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.40811106 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40250437 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39926329 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39669115 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.37769230 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36937160 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36576555 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35349722 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35157465 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34980187 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34448745 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33831963 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30730228 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30136064 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29451014 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28547216 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27487973 |

